Enhance Clinical Outcomes

When even one inaccurate or delayed result can mean a life is on the line, you can count on Ortho Systems’ strong record of accuracy to deliver consistent results you can trust — and confidence in your treatment decisions.  

You are currently viewing the solution for:

Transfusion Medicine

Chemistry and Immunodiagnostics

Improve Consistency in Complex Testing

When patients are waiting for lifesaving blood, our solutions brings you automated testing with rapid, reliable turnaround time — even for complex tests. And the ORTHO VISION® Platform is the only analyzer currently automating serial dilutions for titration studies. That means reduced risk for errors associated with manual testing. Read More

Reduce Manual Error and Variability for Safe, Reliable Outcomes

Manual testing can mean increased risk of interferences and errors when preparing donor blood for patients in need. The ORTHO VISION® Platform locks in reliability with automated, standardized processes and reporting, reducing the risk of inconsistency and manual intervention. Read More

Delivering Complete, Flexible Solutions

Our solutions feature a comprehensive, flexible testing menu — including antigen profile testing — that helps you achieve maximum efficiency and standardization while minimizing the potential for error. Read More

Expect More from Extended Phenotyping

Extended antigen typing has met its match in the ORTHO Sera suite of reagents. Covering 99% of the most commonly tested antigens, ORTHO Sera on the ORTHO VISION® Platform distills even complex testing down to just three easy steps.

Fast, Accurate Results the First Time

A 96.5% first pass yield with VITROS systems gives you confidence that stressful repeat blood draws and tests can be avoided. VITROS provides accurate results the first time so physicians can make faster treatment decisions for their patients. Read More

Improve Patient Management

Electrolyte values are impacted by abnormal levels of protein and lipid in the blood, when measured using indirect ion specific electrodes. Only Ortho's systems use direct ISEs which are not impacted by abnormal levels of proteins and lipids as compared to competitive indirect methods. Read More

Minimize Impact of Interferences

Paraproteins can interfere with lab assays and lead to incorrect diagnoses. But VITROS® MicroSlide Technology removes paraproteins from samples before they ever touch reagents — bringing reliable results and confident treatment decisions.Read More

Other Solutions you might be interested in

Need advice?

Our smart Solution Finder will get you started on how together we can reimagine your lab!

Prefer speaking to someone? Let's talk

Related resources and education

Press Release 10/23/2019

VITROS®️ MicroSlide Technology Recognized as 'Innovative Water Saving Product' by Confederation of Indian Industry

VITROS®️ MicroSlide Technology From Ortho Clinical Diagnostics Recognized as ‘Innovative Water Saving Product’ by Confederation of Indian Industry
Press Release 10/18/2019

The FDA Clears ORTHO™ Sera ID-MTS for Use on the ORTHO VISION® Analyzer

FDA Clears ORTHO™ Sera ID-MTS for Use on the ORTHO VISION® Analyzer
Press Release 08/27/2019

New CEO - Chris Smith Named Next Chief Executive Officer of Ortho Clinical Diagnostics

Chris Smith Named Next Chief Executive Officer of Ortho Clinical Diagnostics
Article 10/07/2019

Join the Fight - Why the Laboratory Is at the Forefront of the Global Fight Against HIV

Why the Laboratory Is at the Forefront of the Global Fight Against HIV

Together we can find a solution